Resources

Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cellular therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases.

Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cellular therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases.

Precigen’s headquarters are located at:
20358 Seneca Meadows Parkway
Germantown, Maryland 20876
Telephone (301) 556-9900

Shares of Precigen trade on the NASDAQ global select market exchange under the symbol PGEN.